metoclopramide has been researched along with Obesity in 13 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was designed to investigate the influence of body weight on the prolactin responsiveness to metoclopramide and thyrotrophin-releasing hormone (TRH) in secondary amenorrhoeic women." | 9.07 | Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women. ( Aono, T; Higuchi, K; Morishita, H; Takemoto, M; Yoshida, J, 1994) |
| "We have previously reported an impaired arginine vasopressin (AVP) response to insulin-induced hypoglycemia in obese men, suggesting a hypothalamic-posterior pituitary disorder in obesity." | 7.68 | Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking. ( Bianconi, L; Caiazza, A; Capretti, L; Chiodera, P; Coiro, V; Davoli, C, 1990) |
| "The present study was designed to investigate the influence of body weight on the prolactin responsiveness to metoclopramide and thyrotrophin-releasing hormone (TRH) in secondary amenorrhoeic women." | 5.07 | Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women. ( Aono, T; Higuchi, K; Morishita, H; Takemoto, M; Yoshida, J, 1994) |
| "We have previously reported an impaired arginine vasopressin (AVP) response to insulin-induced hypoglycemia in obese men, suggesting a hypothalamic-posterior pituitary disorder in obesity." | 3.68 | Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking. ( Bianconi, L; Caiazza, A; Capretti, L; Chiodera, P; Coiro, V; Davoli, C, 1990) |
| " This diabetes insipidus is reversible, non-progressive, unrelated to plasma level, and distinct in attack from lithium-induced hypothyroidism, which may occur at low dosage but is also usually of late onset and reversible or treatable with thyroxine while lithium is continued." | 3.65 | Blood levels and management of lithium treatment. ( Crammer, JL; Crane, G; Rosser, RM, 1974) |
| "Busulfan was quantitated in plasma samples at 10 time points within the 6 h dosing interval using HPLC before and after dose numbers 1, 2, 5, 13 and 14." | 1.29 | Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted? ( Blanz, J; Ehninger, G; Kühnle, A; Kumbier, I; Mewes, K; Proksch, B; Schroer, S; Schuler, U; Zeller, KP, 1994) |
| "Naloxone did not cause any significant change in beta-endorphin release." | 1.27 | The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity. ( Baranowska, B; Jeske, W; Nowakowski, J; Singh, SP; Soszynski, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzsimons, NJ | 1 |
| Sun, LL | 1 |
| Dahm, P | 1 |
| Moul, JW | 1 |
| Madden, J | 1 |
| Gan, TJ | 1 |
| Freedland, SJ | 1 |
| Schuler, U | 1 |
| Schroer, S | 1 |
| Kühnle, A | 1 |
| Blanz, J | 1 |
| Mewes, K | 1 |
| Kumbier, I | 1 |
| Proksch, B | 1 |
| Zeller, KP | 1 |
| Ehninger, G | 1 |
| Takemoto, M | 1 |
| Morishita, H | 1 |
| Higuchi, K | 1 |
| Yoshida, J | 1 |
| Aono, T | 1 |
| Cunha-Filho, JS | 1 |
| Gross, JL | 1 |
| Vettori, D | 1 |
| Dias, EC | 1 |
| Passos, EP | 1 |
| Röjdmark, S | 1 |
| Rössner, S | 1 |
| Chiodera, P | 1 |
| Capretti, L | 1 |
| Davoli, C | 1 |
| Caiazza, A | 1 |
| Bianconi, L | 1 |
| Coiro, V | 1 |
| Baranowska, B | 1 |
| Singh, SP | 1 |
| Soszynski, P | 1 |
| Nowakowski, J | 1 |
| Jeske, W | 1 |
| Barbarino, A | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| D'Amico, C | 1 |
| Sambo, P | 1 |
| Passeri, M | 1 |
| Anile, C | 1 |
| Maira, G | 1 |
| Laws, HL | 1 |
| Bryant, JW | 1 |
| Palmer, MD | 1 |
| Boudreaux, AM | 1 |
| Donald, JM | 1 |
| Wheeler, AS | 1 |
| Lam, AM | 1 |
| Grace, DM | 1 |
| Manninen, PH | 1 |
| Diamond, C | 1 |
| Hasen, J | 1 |
| Shalit, S | 1 |
| Manchikanti, L | 1 |
| Roush, JR | 1 |
| Colliver, JA | 1 |
| Crammer, JL | 1 |
| Rosser, RM | 1 |
| Crane, G | 1 |
3 trials available for metoclopramide and Obesity
| Article | Year |
|---|---|
Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women.
Topics: Adult; Amenorrhea; Body Weight; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Lu | 1994 |
Effects of preoperative medications on gastric pH, volume, and flora.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Gastric Juice; Gastrostomy; Hu | 1986 |
The effects of cimetidine and ranitidine with and without metoclopramide on gastric volume and pH in morbidly obese patients.
Topics: Adult; Cimetidine; Female; Gastric Acidity Determination; Gastric Emptying; Gastrointestinal Content | 1986 |
10 other studies available for metoclopramide and Obesity
| Article | Year |
|---|---|
A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathological outcomes for obese men: an analysis of the Duke Prostate Center database.
Topics: Blood Loss, Surgical; Body Mass Index; Humans; Male; Metoclopramide; Middle Aged; Obesity; Prostatec | 2007 |
Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted?
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Drug Monitoring; Eating; Female; He | 1994 |
Growth hormone and prolactin secretion after metoclopramide administration (DA2 receptor blockade) in fertile women.
Topics: Adult; Blood Glucose; Cross-Sectional Studies; Dopamine D2 Receptor Antagonists; Estradiol; Female; | 2001 |
Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting.
Topics: Administration, Oral; Dopamine; Dose-Response Relationship, Drug; Fasting; Humans; Injections, Intra | 1991 |
Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking.
Topics: Adult; Arginine Vasopressin; Humans; Kinetics; Male; Metoclopramide; Nicotine; Obesity; Reference Va | 1990 |
The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; beta-Endorphin; Clonidine; Female; Growth Hormone; Hum | 1987 |
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure.
Topics: Adult; Empty Sella Syndrome; Female; Humans; Intracranial Pressure; Metoclopramide; Nomifensine; Obe | 1987 |
Specific prolactin release refractoriness to thyroid-stimulating hormone-releasing factor in an obese infertile man.
Topics: Adult; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hydroco | 1985 |
Effect of preanesthetic ranitidine and metoclopramide on gastric contents in morbidly obese patients.
Topics: Adult; Gastric Acidity Determination; Gastrointestinal Contents; Humans; Metoclopramide; Middle Aged | 1986 |
Blood levels and management of lithium treatment.
Topics: Administration, Oral; Adult; Aged; Carbimazole; Delayed-Action Preparations; Dementia; Depression; D | 1974 |